SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-084768
Filing Date
2024-04-02
Accepted
2024-04-02 16:23:21
Documents
7
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d769033ddef14a.htm DEF 14A 682764
2 GRAPHIC g769033dsp65.jpg GRAPHIC 8289
3 GRAPHIC g769033dsp65a.jpg GRAPHIC 2765
4 GRAPHIC g769033dsp66.jpg GRAPHIC 4854
5 GRAPHIC g769033g01a03.jpg GRAPHIC 54146
6 GRAPHIC g769033g63a70.jpg GRAPHIC 90271
7 GRAPHIC g769033g80h57.jpg GRAPHIC 87284
  Complete submission text file 0001193125-24-084768.txt   1025837
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38624 | Film No.: 24814594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)